Literature DB >> 19434876

Testosterone enhances estradiol's effects on postmenopausal bone density and sexuality.

Susan R Davis1, Philip McCloud, Boyd J G Strauss, Henry Burger.   

Abstract

To investigate the role of androgens in increasing bone density and improving low libido in postmenopausal women, we have studied the long-term effects of estradiol and testosterone implants on bone mineral density and sexuality in a prospective, 2 year, single-blind randomised trial. Thirty-four postmenopausal volunteers were randomised to treatment with either estradiol implants 50 mg alone (E) or estradiol 50 mg plus testosterone 50 mg (E&amp;T), administered 3-monthly for 2 years. Cyclical oral progestins were taken by those women with an intact uterus. Thirty-two women completed the study. BMD (DEXA) of total body, lumbar vertebrae (L1-L4) and hip area increased significantly in both treatment groups. BMD increased more rapidly in the testosterone treated group at all sites. A substantially greater increase in BMD occurred in the E&amp;T group for total body (P < 0.008), vertebral L1-L4 (P < 0.001) and trochanteric (P < 0.005) measurements. All sexual parameters (Sabbatsberg sexual self-rating scale) improved significantly in both groups. Addition of testosterone resulted in a significantly greater improvement compared to E for sexual activity (P < 0.03), satisfaction (P < 0.03), pleasure (P < 0.01), orgasm (P < 0.035) and relevancy (P < 0.05). Total cholesterol and LDL-cholesterol fell in both groups as did total body fat. Total body fat-free mass (DEXA, anthropometry, impedance) increased in the E&amp;T group only. We concluded that in postmenopausal women, treatment with combined estradiol and testosterone implants was more effective in increasing bone mineral density in the hip and lumbar spine than estradiol implants alone. Significantly greater improvement in sexuality was observed with combined therapy, verifying the therapeutic value of testosterone implants for diminished libido in postmenopausal women. The favourable estrogenic effects on lipids were preserved in women treated with T, in association with beneficial changes in body composition.

Entities:  

Year:  2008        PMID: 19434876     DOI: 10.1016/j.maturitas.2008.09.006

Source DB:  PubMed          Journal:  Maturitas        ISSN: 0378-5122            Impact factor:   4.342


  8 in total

Review 1.  Hormone treatment and muscle anabolism during aging: androgens.

Authors:  E Lichar Dillon; William J Durham; Randall J Urban; Melinda Sheffield-Moore
Journal:  Clin Nutr       Date:  2010-05-07       Impact factor: 7.324

2.  Nonsteroidal selective androgen receptor modulators enhance female sexual motivation.

Authors:  Amanda Jones; Dong Jin Hwang; Charles B Duke; Yali He; Anjaiah Siddam; Duane D Miller; James T Dalton
Journal:  J Pharmacol Exp Ther       Date:  2010-05-05       Impact factor: 4.030

Review 3.  Clinical review: The benefits and harms of systemic testosterone therapy in postmenopausal women with normal adrenal function: a systematic review and meta-analysis.

Authors:  Tarig Elraiyah; Mohamad Bassam Sonbol; Zhen Wang; Tagwa Khairalseed; Noor Asi; Chaitanya Undavalli; Mohammad Nabhan; Belal Firwana; Osama Altayar; Larry Prokop; Victor M Montori; Mohammad Hassan Murad
Journal:  J Clin Endocrinol Metab       Date:  2014-10       Impact factor: 5.958

Review 4.  The role of androgens and estrogens on healthy aging and longevity.

Authors:  Astrid M Horstman; E Lichar Dillon; Randall J Urban; Melinda Sheffield-Moore
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-03-26       Impact factor: 6.053

5.  Environmental exposure to di-2-ethylhexyl phthalate is associated with low interest in sexual activity in premenopausal women.

Authors:  Emily S Barrett; Lauren E Parlett; Christina Wang; Erma Z Drobnis; J Bruce Redmon; Shanna H Swan
Journal:  Horm Behav       Date:  2014-11-08       Impact factor: 3.587

6.  Sexual function in elderly women: a review of current literature.

Authors:  Dana R Ambler; Eric J Bieber; Michael P Diamond
Journal:  Rev Obstet Gynecol       Date:  2012

Review 7.  Androgens and Androgen Receptor Actions on Bone Health and Disease: From Androgen Deficiency to Androgen Therapy.

Authors:  Jia-Feng Chen; Pei-Wen Lin; Yi-Ru Tsai; Yi-Chien Yang; Hong-Yo Kang
Journal:  Cells       Date:  2019-10-25       Impact factor: 6.600

8.  Effects of Abelmoschus manihot Flower Extract on Enhancing Sexual Arousal and Reproductive Performance in Zebrafish.

Authors:  Chi-Chang Chang; Jer-Yiing Houng; Wei-Hao Peng; Tien-Wei Yeh; Yun-Ya Wang; Ya-Ling Chen; Tzu-Hsien Chang; Wei-Chin Hung; Teng-Hung Yu
Journal:  Molecules       Date:  2022-03-29       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.